Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.
Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice.
Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder.
Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.
Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis.
Docosahexaenoic Acid and Cognition throughout the Lifespan.
Long-term effects of intrathecal baclofen in multiple sclerosis.
CCR5 knockout suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice.
Activation of the adenosine A2A receptor exacerbates experimental autoimmune neuritis in Lewis rats in association with enhanced humoral immunity.
Dimethyl fumarate (Tecfidera) for multiple sclerosis.
Transcription factors and th17 cell development in experimental autoimmune encephalomyelitis.
2010 McDonald criteria in a pediatric cohort: is positivity at onset associated with a more aggressive multiple sclerosis course?
Socioeconomic Factors in Childhood and the Risk of Multiple Sclerosis.
Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments.
Multiple sclerosis documentation system (MSDS): moving from documentation to management of MS patients.
Specialized housing and transportation needs of adults with multiple sclerosis.
Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis.
Acute Disseminated Encephalomyelitis in Children and Adolescents: A Single Center Experience.
Neuroimaging assessment of spasticity developed after acquired brain injuries and multiple sclerosis.
Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems.
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.
FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity.
Adjusted Indirect Comparison of Oral Multiple Sclerosis Agents.
Multimodal neurophysiological evaluation of primary progressive multiple sclerosis - An increasingly valid biomarker, with limits.
Pages
« first
‹ previous
…
548
549
550
551
552
553
554
555
556
…
next ›
last »